International Consensus Document (ICON): Common Variable Immunodeficiency Disorders

Journal of Allergy and Clinical Immunology: In Practice

Volumn 4, Issue 1, 2016, Pages 38-59

  Bonilla, Francisco A ^a   Barlan, Isil ^b   Chapel, Helen ^c   Costa Carvalho, Beatriz T ^d   Cunningham Rundles, Charlotte ^e   de la Morena, M Teresa ^f   Espinosa Rosales, Francisco J ^g   Hammarström, Lennart ^h   Nonoyama, Shigeaki ⁱ   Quinti, Isabella ^j   Routes, John M ^k   Tang, Mimi L K ^l   Warnatz, Klaus ^m  

^a BOSTON CHILDREN S HOSPITAL   (United States)

^b MARMARA UNIVERSITY   (Turkey)

^c UNIVERSITY OF OXFORD   (United Kingdom)

^d FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

^e MOUNT SINAI MEDICAL CENTER   (United States)

^f UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^g INSTITUTO NACIONAL DE PEDIATRÍA   (Mexico)

^h KAROLINSKA INSTITUTE   (Sweden)

ⁱ NATIONAL DEFENSE MEDICAL COLLEGE   (Japan)

^j SAPIENZA UNIVERSITY OF ROME   (Italy)

^k Children's Hospital of Wisconsin   (United States)

^l UNIVERSITY OF MELBOURNE   (Australia)

^m UNIVERSITY OF FREIBURG   (Germany)

more..

Author keywords

[No Author keywords available]

Indexed keywords

AMINOGLYCOSIDE ANTIBIOTIC AGENT; AZATHIOPRINE; AZITHROMYCIN; BUDESONIDE; CORTICOSTEROID; IMMUNOGLOBULIN; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; INFLIXIMAB; MERCAPTOPURINE; MESALAZINE; PREDNISONE;

AGE DISTRIBUTION; ANTIBODY PRODUCTION; AUTOIMMUNE HEMOLYTIC ANEMIA; AUTOIMMUNITY; B LYMPHOCYTE; BRONCHIECTASIS; CELL PROLIFERATION; CHRONIC LUNG DISEASE; CLINICAL FEATURE; COMMON VARIABLE IMMUNODEFICIENCY SYNDROME; CYTOPENIA; DENDRITIC CELL; DISEASE REGISTRY; ENTEROPATHY; FLOW CYTOMETRY; GASTROINTESTINAL DISEASE; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; GRANULOMA; GRANULOMATOSIS; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMAN; IDIOPATHIC THROMBOCYTOPENIC PURPURA; IMMUNE DEFICIENCY; IMMUNOGLOBULIN BLOOD LEVEL; IMMUNOGLOBULIN DEFICIENCY; IMMUNOMODULATION; IMMUNOPHENOTYPING; INCIDENCE; INNATE IMMUNITY; INTERSTITIAL LUNG DISEASE; LINKAGE ANALYSIS; LOW DRUG DOSE; LYMPHOCYTE PROLIFERATION; LYMPHOID HYPERPLASIA; MEDIASTINUM LYMPHADENOPATHY; MEMORY CELL; MORTALITY; PATHOGENESIS; PHENOTYPE; PREVALENCE; REVIEW; RHINOSINUSITIS; SEX DIFFERENCE; SINGLE NUCLEOTIDE POLYMORPHISM; T LYMPHOCYTE; URINARY TRACT INFECTION; AGAMMAGLOBULINEMIA; AGE; ALGORITHM; COMMON VARIABLE IMMUNODEFICIENCY; CONSENSUS DEVELOPMENT; DIFFERENTIAL DIAGNOSIS; EXPERT WITNESS; IMMUNOLOGY; INTERNATIONAL COOPERATION;

AGAMMAGLOBULINEMIA; AGE FACTORS; ALGORITHMS; B-LYMPHOCYTES; COMMON VARIABLE IMMUNODEFICIENCY; DIAGNOSIS, DIFFERENTIAL; EXPERT TESTIMONY; HUMANS; IMMUNOPHENOTYPING; INTERNATIONAL COOPERATION;

EID: 84953776209     PISSN: 22132198     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jaip.2015.07.025     Document Type: Review

References (259)

1. Fudenberg H., Good R.A., Goodman H.C., Hitzig W., Kunkel H.G., Roitt I.M., et al. Primary immunodeficiencies: report of a World Health Organization Committee. Pediatrics 1971, 47:927-946.
2. Cooper M.D., Faulk W.P., Fudenberg H.H., Good R.A., Hitzig W., Kunkel H., et al. Classification of primary immunodeficiencies. N Engl J Med 1973, 288:966-967.
3. Notarangelo L.D., Fischer A., Geha R.S., Casanova J.L., Chapel H., Conley M.E., et al. Primary immunodeficiencies: 2009 update. J Allergy Clin Immunol 2009, 124:1161-1178.
4. Orange J.S., Glessner J.T., Resnick E., Sullivan K.E., Lucas M., Ferry B., et al. Genome-wide association identifies diverse causes of common variable immunodeficiency. J Allergy Clin Immunol 2011, 127:1360-1367.e6.
5. Yong P.F., Thaventhiran J.E., Grimbacher B. "A rose is a rose is a rose," but CVID is not CVID common variable immune deficiency (CVID), what do we know in 2011?. Adv Immunol 2011, 111:47-107.
6. Keller M.D., Jyonouchi S. Chipping away at a mountain: genomic studies in common variable immunodeficiency. Autoimmun Rev 2013, 12:687-689.
7. Kutukculer N., Karaca N.E., Demircioglu O., Aksu G. Increases in serum immunoglobulins to age-related normal levels in children with IgA and/or IgG subclass deficiency. Pediatr Allergy Immunol 2007, 18:167-173.
8. Chapel H., Lucas M., Patel S., Lee M., Cunningham-Rundles C., Resnick E., et al. Confirmation and improvement of criteria for clinical phenotyping in common variable immunodeficiency disorders in replicate cohorts. J Allergy Clin Immunol 2012, 130:1197-1198.e9.
9. Malphettes M., Gerard L., Carmagnat M., Mouillot G., Vince N., Boutboul D., et al. Late-onset combined immune deficiency: a subset of common variable immunodeficiency with severe T cell defect. Clin Infect Dis 2009, 49:1329-1338.
10. Agarwal S., Cunningham-Rundles C. Autoimmunity in common variable immunodeficiency. Curr Allergy Asthma Rep 2009, 9:347-352.
11. Quinti I., Soresina A., Spadaro G., Martino S., Donnanno S., Agostini C., et al. Long-term follow-up and outcome of a large cohort of patients with common variable immunodeficiency. J Clin Immunol 2007, 27:308-316.
12. Chapel H., Cunningham-Rundles C. Update in understanding common variable immunodeficiency disorders (CVIDs) and the management of patients with these conditions. Br J Haematol 2009, 145:709-727.
13. Cunningham-Rundles C. How I treat common variable immune deficiency. Blood 2010, 116:7-15.
14. Kardar G., Oraei M., Shahsavani M., Namdar Z., Kazemisefat G., Haghi Ashtiani M., et al. Reference intervals for serum immunoglobulins IgG, IgA, IgM and complements C3 and C4 in Iranian healthy children. Iran J Public Health 2012, 41:59-63.
15. Ozen A., Baris S., Karakoc-Aydiner E., Ozdemir C., Bahceciler N.N., Barlan I.B. Outcome of hypogammaglobulinemia in children: immunoglobulin levels as predictors. Clin Immunol 2010, 137:374-383.
16. Ameratunga R., Woon S.T., Gillis D., Koopmans W., Steele R. New diagnostic criteria for CVID. Expert Rev Clin Immunol 2014, 10:183-186.
17. Aghamohammadi A., Moein M., Farhoudi A., Pourpak Z., Rezaei N., Abolmaali K., et al. Primary immunodeficiency in Iran: first report of the National Registry of PID in Children and Adults. J Clin Immunol 2002, 22:375-380.
18. Gathmann B., Binder N., Ehl S., Pourpak Z., Rezaei N., Abolmaali K. The European internet-based patient and research database for primary immunodeficiencies: update 2011. Clin Exp Immunol 2012, 167:479-491.
19. Golan H., Dalal I., Garty B.Z., Schlesinger M., Levy J., Handzel Z., et al. The incidence of primary immunodeficiency syndromes in Israel. Isr Med Assoc J 2002, 4:868-871.
20. Leiva L.E., Zelazco M., Oleastro M., Carneiro-Sampaio M., Condino-Neto A., Costa-Carvalho B.T., et al. Primary immunodeficiency diseases in Latin America: the second report of the LAGID registry. J Clin Immunol 2007, 27:101-108.
21. Lim D.L., Thong B.Y., Ho S.Y., Shek L.P., Lou J., Leong K.P., et al. Primary immunodeficiency diseases in Singapore-the last 11 years. Singapore Med J 2003, 44:579-586.
22. Boyle J.M., Buckley R.H. Population prevalence of diagnosed primary immunodeficiency diseases in the United States. J Clin Immunol 2007, 27:497-502.
23. Rachid R., Bonilla F.A. The role of anti-IgA antibodies in causing adverse reactions to gamma globulin infusion in immunodeficient patients: a comprehensive review of the literature. J Allergy Clin Immunol 2012, 129:628-634.
24. Javier F.C., Moore C.M., Sorensen R.U. Distribution of primary immunodeficiency diseases diagnosed in a pediatric tertiary hospital. Ann Allergy Asthma Immunol 2000, 84:25-30.
25. Immunodeficiencies ESf. New ESID Registry 2013. Available from:. Accessed November 15, 2014. http://esid.org/Working-Parties/Registry/New-ESID-Registry.
26. Network USI. USIDNET Registry. Towson, MD: Immune Deficiency Foundation; 2014. Available from: Accessed September 22, 2014. http://www.usidnet.org/pub/Registries-Info.
27. Ishimura M., Takada H., Doi T., Imai K., Sasahara Y., Kanegane H., et al. Nationwide survey of patients with primary immunodeficiency diseases in Japan. J Clin Immunol 2011, 31:968-976.
28. Warnatz K., Denz A., Drager R., Braun M., Groth C., Wolff-Vorbeck G., et al. Severe deficiency of switched memory B cells (CD27(+)IgM(-)IgD(-)) in subgroups of patients with common variable immunodeficiency: a new approach to classify a heterogeneous disease. Blood 2002, 99:1544-1551.
29. Wehr C., Kivioja T., Schmitt C., Ferry B., Witte T., Eren E., et al. The EUROclass trial: defining subgroups in common variable immunodeficiency. Blood 2008, 111:77-85.
30. Ochtrop M.L., Goldacker S., May A.M., Rizzi M., Draeger R., Hauschke D., et al. T and B lymphocyte abnormalities in bone marrow biopsies of common variable immunodeficiency. Blood 2011, 118:309-318.
31. Taubenheim N., von Hornung M., Durandy A., Warnatz K., Corcoran L., Peter H.H., et al. Defined blocks in terminal plasma cell differentiation of common variable immunodeficiency patients. J Immunol 2005, 175:5498-5503.
32. Bryant A., Calver N.C., Toubi E., Webster A.D., Farrant J. Classification of patients with common variable immunodeficiency by B cell secretion of IgM and IgG in response to anti-IgM and interleukin-2. Clin Immunol Immunopathol 1990, 56:239-248.
33. Driessen G.J., van Zelm M.C., van Hagen P.M., Hartwig N.G., Trip M., Warris A., et al. B-cell replication history and somatic hypermutation status identify distinct pathophysiologic backgrounds in common variable immunodeficiency. Blood 2011, 118:6814-6823.
34. Foerster C., Voelxen N., Rakhmanov M., Keller B., Gutenberger S., Goldacker S., et al. B cell receptor-mediated calcium signaling is impaired in B lymphocytes of type Ia patients with common variable immunodeficiency. J Immunol 2010, 184:7305-7313.
35. Marron T.U., Yu J.E., Cunningham-Rundles C. Toll-like receptor function in primary B cell defects. Front Biosci (Elite Ed) 2012, 4:1853-1863.
36. Giovannetti A., Pierdominici M., Aiuti F. T-cell homeostasis: the dark(ened) side of common variable immunodeficiency. Blood 2008, 112:446. author reply 446-7.
37. Funauchi M., Farrant J., Moreno C., Webster A.D. Defects in antigen-driven lymphocyte responses in common variable immunodeficiency (CVID) are due to a reduction in the number of antigen-specific CD4+ T cells. Clin Exp Immunol 1995, 101:82-88.
38. Stagg A.J., Funauchi M., Knight S.C., et al. Failure in antigen responses by T cells from patients with common variable immunodeficiency (CVID). Clin Exp Immunol 1994, 96:48-53.
39. Thon V., Eggenbauer H., Wolf H.M., Fischer M.B., Litzman J., Lokaj J., et al. Antigen presentation by common variable immunodeficiency (CVID) B cells and monocytes is unimpaired. Clin Exp Immunol 1997, 108:1-8.
40. Fischer M.B., Hauber I., Vogel E., Wolf H.M., Mannhalter J.W., Eibl MM. Defective interleukin-2 and interferon-gamma gene expression in response to antigen in a subgroup of patients with common variable immunodeficiency. J Allergy Clin Immunol 1993, 92:340-352.
41. Holm A.M., Aukrust P., Aandahl E.M., Muller F., Tasken K., Froland S.S. Impaired secretion of IL-10 by T cells from patients with common variable immunodeficiency-involvement of protein kinase A type I. J Immunol 2003, 170:5772-5777.
42. Adelman D.C., Matsuda T., Hirano T., Kishimoto T., Saxon A. Elevated serum interleukin-6 associated with a failure in B cell differentiation in common variable immunodeficiency. J Allergy Clin Immunol 1990, 86:512-521.
43. Martinez-Pomar N., Raga S., Ferrer J., Pons J., Munoz-Saa I., Julia M.R., et al. Elevated serum interleukin (IL)-12p40 levels in common variable immunodeficiency disease and decreased peripheral blood dendritic cells: analysis of IL-12p40 and interferon-gamma gene. Clin Exp Immunol 2006, 144:233-238.
44. Bateman E.A., Ayers L., Sadler R., Lucas M., Roberts C., Woods A., et al. T cell phenotypes in patients with common variable immunodeficiency disorders: associations with clinical phenotypes in comparison with other groups with recurrent infections. Clin Exp Immunol 2012, 170:202-211.
45. Guazzi V., Aiuti F., Mezzaroma I., Mazzetta F., Andolfi G., Mortellaro A., et al. Assessment of thymic output in common variable immunodeficiency patients by evaluation of T cell receptor excision circles. Clin Exp Immunol 2002, 129:346-353.
46. Kamae C., Nakagawa N., Sato H., Honma K., Mitsuiki N., Ohara O., et al. Common variable immunodeficiency classification by quantifying T-cell receptor and immunoglobulin kappa-deleting recombination excision circles. J Allergy Clin Immunol 2013, 131:1437-1440.e5.
47. Scott-Taylor T.H., Green M.R., Raeiszadeh M., Workman S., Webster A.D. Defective maturation of dendritic cells in common variable immunodeficiency. Clin Exp Immunol 2006, 145:420-427.
48. Yu J.E., Knight A.K., Radigan L., Marron T.U., Zhang L., Sanchez-Ramon S., et al. Toll-like receptor 7 and 9 defects in common variable immunodeficiency. J Allergy Clin Immunol 2009, 124:349-356. 356.e1-3.
49. Aspalter R.M., Sewell W.A., Dolman K., Gerard L., Oksenhendler E., Warnatz K., et al. Deficiency in circulating natural killer (NK) cell subsets in common variable immunodeficiency and X-linked agammaglobulinaemia. Clin Exp Immunol 2000, 121:506-514.
50. Gathmann B., Mahlaoui N., Ceredih, Gerard L., Oksenhendler E., Warnatz K., et al. Clinical picture and treatment of 2212 patients with common variable immunodeficiency. J Allergy Clin Immunol 2014, 134:116-126.
51. Finck A., Van der Meer J.W., Schaffer A.A., Pfannstiel J., Fieschi C., Plebani A., et al. Linkage of autosomal-dominant common variable immunodeficiency to chromosome 4q. Eur J Hum Genet 2006, 14:867-875.
52. Cunningham-Rundles C., Bodian C. Common variable immunodeficiency: clinical and immunological features of 248 patients. Clin Immunol 1999, 92:34-48.
53. Chapel H., Lucas M., Lee M., Bjorkander J., Webster D., Grimbacher B., et al. Common variable immunodeficiency disorders: division into distinct clinical phenotypes. Blood 2008, 112:277-286.
54. Sanford J.P., Favour C.B., Tribeman M.S. Absence of serum gamma globulins in an adult. N Engl J Med 1954, 250:1027-1029.
55. Boileau J., Mouillot G., Gerard L., Carmagnat M., Rabian C., Oksenhendler E., et al. Autoimmunity in common variable immunodeficiency: correlation with lymphocyte phenotype in the French DEFI study. J Autoimmun 2011, 36:25-32.
56. Oksenhendler E., Gerard L., Fieschi C., Malphettes M., Mouillot G., Jaussaud R., et al. Infections in 252 patients with common variable immunodeficiency. Clin Infect Dis 2008, 46:1547-1554.
57. Resnick E.S., Cunningham-Rundles C. The many faces of the clinical picture of common variable immune deficiency. Curr Opin Allergy Clin Immunol 2012, 12:595-601.
58. Webster A.D., Taylor-Robinson D., Furr P.M., Asherson G.L. Chronic cystitis and urethritis associated with ureaplasmal and mycoplasmal infection in primary hypogammaglobulinaemia. Br J Urol 1982, 54:287-291.
59. Franz A., Webster A.D., Furr P.M., Taylor-Robinson D. Mycoplasmal arthritis in patients with primary immunoglobulin deficiency: clinical features and outcome in 18 patients. Br J Rheumatol 1997, 36:661-668.
60. Pitcher D.G., Windsor D., Windsor H., Bradbury J.M., Yavari C., Jensen J.S., et al. Mycoplasma amphoriforme sp. nov., isolated from a patient with chronic bronchopneumonia. Int J Syst Evol Microbiol 2005, 55:2589-2594.
61. Gelfand E.W. Unique susceptibility of patients with antibody deficiency to mycoplasma infection. Clin Infect Dis 1993, 17:S250-S253.
62. Halliday E., Winkelstein J., Webster A.D. Enteroviral infections in primary immunodeficiency (PID): a survey of morbidity and mortality. J Infect 2003, 46:1-8.
63. Busse P.J., Razvi S., Cunningham-Rundles C. Efficacy of intravenous immunoglobulin in the prevention of pneumonia in patients with common variable immunodeficiency. J Allergy Clin Immunol 2002, 109:1001-1004.
64. Kainulainen L., Nikoskelainen J., Vuorinen T., Tevola K., Liippo K., Ruuskanen O. Viruses and bacteria in bronchial samples from patients with primary hypogammaglobulinemia. Am J Respir Crit Care Med 1999, 159:1199-1204.
65. Maglione P.J., Overbey J.R., Radigan L., Bagiella E., Cunningham-Rundles C. Pulmonary radiologic findings in common variable immunodeficiency: clinical and immunological correlations. Ann Allergy Asthma Immunol 2014, 113:452-459.
66. Gregersen S., Aalokken T.M., Mynarek G., Fevang B., Holm A.M., Ueland T., et al. Development of pulmonary abnormalities in patients with common variable immunodeficiency: associations with clinical and immunologic factors. Ann Allergy Asthma Immunol 2010, 104:503-510.
67. Bates C.A., Ellison M.C., Lynch D.A., Cool C.D., Brown K.K., Routes J.M. Granulomatous-lymphocytic lung disease shortens survival in common variable immunodeficiency. J Allergy Clin Immunol 2004, 114:415-421.
68. Morimoto Y., Routes J.M. Granulomatous disease in common variable immunodeficiency. Curr Allergy Asthma Rep 2005, 5:370-375.
69. Maarschalk-Ellerbroek L.J., de Jong P.A., van Montfrans J.M., Lammers J.W., Bloem A.C., Hoepelman A.I., et al. CT screening for pulmonary pathology in common variable immunodeficiency disorders and the correlation with clinical and immunological parameters. J Clin Immunol 2014, 34:642-654.
70. Quinti I., Agostini C., Tabolli S., Brunetti G., Cinetto F., Pecoraro A., et al. Malignancies are the major cause of death in patients with adult onset common variable immunodeficiency. Blood 2012, 120:1953-1954.
71. Resnick E.S., Moshier E.L., Godbold J.H., Cunningham-Rundles C. Morbidity and mortality in common variable immune deficiency over 4 decades. Blood 2012, 119:1650-1657.
72. Ardeniz O., Cunningham-Rundles C. Granulomatous disease in common variable immunodeficiency. Clin Immunol 2009, 133:198-207.
73. Cunningham-Rundles C. Common variable immunodeficiency. Curr Allergy Asthma Rep 2001, 1:421-429.
74. Fasano M.B., Sullivan K.E., Sarpong S.B., Wood R.A., Jones S.M., Johns C.J., et al. Sarcoidosis and common variable immunodeficiency: report of 8 cases and review of the literature. Medicine (Baltimore) 1996, 75:251-261.
75. Knight A.K., Cunningham-Rundles C. Inflammatory and autoimmune complications of common variable immune deficiency. Autoimmun Rev 2006, 5:156-159.
76. Mullighan C.G., Fanning G.C., Chapel H.M., Welsh K.I. TNF and lymphotoxin-alpha polymorphisms associated with common variable immunodeficiency: role in the pathogenesis of granulomatous disease. J Immunol 1997, 159:6236-6241.
77. Park J.H., Levinson A.I. Granulomatous-lymphocytic interstitial lung disease (GLILD) in common variable immunodeficiency (CVID). Clin Immunol 2010, 134:97-103.
78. Boursiquot J.N., Gerard L., Malphettes M., Fieschi C., Galicier L., Boutboul D., et al. Granulomatous disease in CVID: retrospective analysis of clinical characteristics and treatment efficacy in a cohort of 59 patients. J Clin Immunol 2013, 33:84-95.
79. Lin J.H., Liebhaber M., Roberts R.L., Dyer Z., Stiehm E.R. Etanercept treatment of cutaneous granulomas in common variable immunodeficiency. J Allergy Clin Immunol 2006, 117:878-882.
80. Mechanic L.J., Dikman S., Cunningham-Rundles C. Granulomatous disease in common variable immunodeficiency. Ann Intern Med 1997, 127:613-617.
81. Misbah S.A., Spickett G.P., Esiri M.M., Hughes J.T., Matthews W.B., Thompson R.A., et al. Recurrent intra-cranial granulomata presenting as space-occupying lesions in a patient with common variable immunodeficiency. Postgrad Med J 1992, 68:359-362.
82. Bouvry D., Mouthon L., Brillet P.Y., Kambouchner M., Ducroix J.P., Cottin V., et al. Granulomatosis-associated common variable immunodeficiency disorder: a case-control study versus sarcoidosis. Eur Respir J 2013, 41:115-122.
83. Cunningham-Rundles C. Hematologic complications of primary immune deficiencies. Blood Rev 2002, 16:61-64.
84. Michel M., Chanet V., Galicier L., Ruivard M., Levy Y., Hermine O., et al. Autoimmune thrombocytopenic purpura and common variable immunodeficiency: analysis of 21 cases and review of the literature. Medicine (Baltimore) 2004, 83:254-263.
85. Wang J., Cunningham-Rundles C. Treatment and outcome of autoimmune hematologic disease in common variable immunodeficiency (CVID). J Autoimmun 2005, 25:57-62.
86. Oliveira J.B., Bleesing J.J., Dianzani U., Fleisher T.A., Jaffe E.S., Lenardo M.J., et al. Revised diagnostic criteria and classification for the autoimmune lymphoproliferative syndrome (ALPS): report from the 2009 NIH International Workshop. Blood 2010, 116:e35-e40.
87. Podjasek J.C., Abraham R.S. Autoimmune cytopenias in common variable immunodeficiency. Front Immunol 2012, 3:189.
88. Warnatz K., Voll R.E. Pathogenesis of autoimmunity in common variable immunodeficiency. Front Immunol 2012, 3:210.
89. Xiao X., Miao Q., Chang C., Gershwin M.E., Ma X. Common variable immunodeficiency and autoimmunity-an inconvenient truth. Autoimmun Rev 2014, 13:858-864.
90. Maarschalk-Ellerbroek L.J., Hoepelman A.I., van Montfrans J.M., Ellerbroek P.M. The spectrum of disease manifestations in patients with common variable immunodeficiency disorders and partial antibody deficiency in a university hospital. J Clin Immunol 2012, 32:907-921.
91. Agarwal S., Mayer L. Pathogenesis and treatment of gastrointestinal disease in antibody deficiency syndromes. J Allergy Clin Immunol 2009, 124:658-664.
92. Malamut G., Verkarre V., Suarez F., Viallard J.F., Lascaux A.S., Cosnes J., et al. The enteropathy associated with common variable immunodeficiency: the delineated frontiers with celiac disease. Am J Gastroenterol 2010, 105:2262-2275.
93. Aslam A., Misbah S.A., Talbot K., Chapel H. Vitamin E deficiency induced neurological disease in common variable immunodeficiency: two cases and a review of the literature of vitamin E deficiency. Clin Immunol 2004, 112:24-29.
94. Aukrust P., Muller F., Ueland T., Svardal A.M., Berge R.K., Froland S.S. Decreased vitamin A levels in common variable immunodeficiency: vitamin A supplementation in vivo enhances immunoglobulin production and downregulates inflammatory responses. Eur J Clin Invest 2000, 30:252-259.
95. Daniels J.A., Lederman H.M., Maitra A., Montgomery E.A. Gastrointestinal tract pathology in patients with common variable immunodeficiency (CVID): a clinicopathologic study and review. Am J Surg Pathol 2007, 31:1800-1812.
96. Venhoff N., Emmerich F., Neagu M., Salzer U., Koehn C., Driever S., et al. The role of HLA DQ2 and DQ8 in dissecting celiac-like disease in common variable immunodeficiency. J Clin Immunol 2013, 33:909-916.
97. Malamut G., Ziol M., Suarez F., Beaugrand M., Viallard J.F., Lascaux A.S., et al. Nodular regenerative hyperplasia: the main liver disease in patients with primary hypogammaglobulinemia and hepatic abnormalities. J Hepatol 2008, 48:74-82.
98. Ward C., Lucas M., Piris J., Collier J., Chapel H. Abnormal liver function in common variable immunodeficiency disorders due to nodular regenerative hyperplasia. Clin Exp Immunol 2008, 153:331-337.
99. Fuss I.J., Friend J., Yang Z., He J.P., Hooda L., Boyer J., et al. Nodular regenerative hyperplasia in common variable immunodeficiency. J Clin Immunol 2013, 33:748-758.
100. Agondi R.C., Barros M.T., Rizzo L.V., Kalil J., Giavina-Bianchi P. Allergic asthma in patients with common variable immunodeficiency. Allergy 2010, 65:510-515.
101. Agondi R.C., Barros M.T., Kokron C.M., Cohon A., Oliveira A.K., Kalil J., et al. Can patients with common variable immunodeficiency have allergic rhinitis?. Am J Rhinol Allergy 2013, 27:79-83.
102. Ozcan C., Metin A., Erkocoglu M., Kocabas C.N. Allergic diseases in children with primary immunodeficiencies. Turk J Pediatr 2014, 56:41-47.
103. Aghamohammadi A., Cheraghi T., Gharagozlou M., Movahedi M., Rezaei N., Yeganeh M., et al. IgA deficiency: correlation between clinical and immunological phenotypes. J Clin Immunol 2009, 29:130-136.
104. Edwards E., Razvi S., Cunningham-Rundles C. IgA deficiency: clinical correlates and responses to pneumococcal vaccine. Clin Immunol 2004, 111:93-97.
105. Elenitoba-Johnson K.S., Jaffe E.S. Lymphoproliferative disorders associated with congenital immunodeficiencies. Semin Diagn Pathol 1997, 14:35-47.
106. Gompels M.M., Hodges E., Lock R.J., Angus B., White H., Larkin A., et al. Lymphoproliferative disease in antibody deficiency: a multi-centre study. Clin Exp Immunol 2003, 134:314-320.
107. Unger S., Seidl M., Schmitt-Graeff A., Bohm J., Schrenk K., Wehr C., et al. Ill-defined germinal centers and severely reduced plasma cells are histological hallmarks of lymphadenopathy in patients with common variable immunodeficiency. J Clin Immunol 2014, 34:615-626.
108. Mellemkjaer L., Hammarstrom L., Andersen V., Yuen J., Heilmann C., Barington T., et al. Cancer risk among patients with IgA deficiency or common variable immunodeficiency and their relatives: a combined Danish and Swedish study. Clin Exp Immunol 2002, 130:495-500.
109. Zullo A., Romiti A., Rinaldi V., Vecchione A., Tomao S., Aiuti F., et al. Gastric pathology in patients with common variable immunodeficiency. Gut 1999, 45:77-81.
110. Ueland T., Froland S.S., Bollerslev J., Aukrust P. Increased levels of biochemical markers of bone turnover in relation to persistent immune activation in common variable immunodeficiency. Eur J Clin Invest 2001, 31:72-78.
111. Baris S., Ozen A., Ercan H., Karakoc-Aydiner E., Cagan H., Ozdemir C., et al. Osteoporosis: an ignored complication of CVID. Pediatr Allergy Immunol 2011, 22:676-683.
112. Ogershok P.R., Hogan M.B., Welch J.E., Corder W.T., Wilson N.W. Spectrum of illness in pediatric common variable immunodeficiency. Ann Allergy Asthma Immunol 2006, 97:653-656.
113. Aghamohammadi A., Mohammadi J., Parvaneh N., Rezaei N., Moin M., Espanol T., et al. Progression of selective IgA deficiency to common variable immunodeficiency. Int Arch Allergy Immunol 2008, 147:87-92.
114. Robinson M., Smart J., Tang M. Common variable immune deficiency disorders: a paediatric experience. Curr Trends Immunol 2008, 9:85-91.
115. Goldacker S., Draeger R., Warnatz K., Huzly D., Salzer U., Thiel J., et al. Active vaccination in patients with common variable immunodeficiency (CVID). Clin Immunol 2007, 124:294-303.
116. Piqueras B., Lavenu-Bombled C., Galicier L., Bergeron-van der Cruyssen F., Mouthon L., Chevret S., et al. Common variable immunodeficiency patient classification based on impaired B cell memory differentiation correlates with clinical aspects. J Clin Immunol 2003, 23:385-400.
117. Warnatz K., Schlesier M. Flowcytometric phenotyping of common variable immunodeficiency. Cytometry B Clin Cytom 2008, 74:261-271.
118. Moratto D., Gulino A.V., Fontana S., Mori L., Pirovano S., Soresina A., et al. Combined decrease of defined B and T cell subsets in a group of common variable immunodeficiency patients. Clin Immunol 2006, 121:203-214.
119. Farrington M., Grosmaire L.S., Nonoyama S., Fischer S.H., Hollenbaugh D., Ledbetter J.A., et al. CD40 ligand expression is defective in a subset of patients with common variable immunodeficiency. Proc Natl Acad Sci U S A 1994, 91:1099-1103.
120. Giovannetti A., Pierdominici M., Mazzetta F., Marziali M., Renzi C., Mileo A.M., et al. Unravelling the complexity of T cell abnormalities in common variable immunodeficiency. J Immunol 2007, 178:3932-3943.
121. Oliva A., Scala E., Quinti I., Paganelli R., Ansotegui I.J., Giovannetti A., et al. IL-10 production and CD40L expression in patients with common variable immunodeficiency. Scand J Immunol 1997, 46:86-90.
122. Kuntz M., Goldacker S., Blum H.E., Pircher H., Stampf S., Peter H.H., et al. Analysis of bulk and virus-specific CD8+ T cells reveals advanced differentiation of CD8+ T cells in patients with common variable immunodeficiency. Clin Immunol 2011, 141:177-186.
123. Arandi N., Mirshafiey A., Jeddi-Tehrani M., Abolhassani H., Sadeghi B., Mirminachi B., et al. Evaluation of CD4+CD25+FOXP3+ regulatory T cells function in patients with common variable immunodeficiency. Cell Immunol 2013, 281:129-133.
124. Horn J., Manguiat A., Berglund L.J., Knerr V., Tahami F., Grimbacher B., et al. Decrease in phenotypic regulatory T cells in subsets of patients with common variable immunodeficiency. Clin Exp Immunol 2009, 156:446-454.
125. Kelesidis T., Yang O. Good's syndrome remains a mystery after 55 years: a systematic review of the scientific evidence. Clin Immunol 2010, 135:347-363.
126. Hammarstrom L., Vorechovsky I., Webster D. Selective IgA deficiency (SIgAD) and common variable immunodeficiency (CVID). Clin Exp Immunol 2000, 120:225-231.
127. Kralovicova J., Hammarstrom L., Plebani A., Webster A.D., Vorechovsky I. Fine-scale mapping at IGAD1 and genome-wide genetic linkage analysis implicate HLA-DQ/DR as a major susceptibility locus in selective IgA deficiency and common variable immunodeficiency. J Immunol 2003, 170:2765-2775.
128. Johnston D.T., Mehaffey G., Thomas J., Young K.R., Wiener H., Li J., et al. Increased frequency of HLA-B44 in recurrent sinopulmonary infections (RESPI). Clin Immunol 2006, 119:346-350.
129. Schaffer A.A., Pfannstiel J., Webster A.D., Plebani A., Hammarstrom L., Grimbacher B. Analysis of families with common variable immunodeficiency (CVID) and IgA deficiency suggests linkage of CVID to chromosome 16q. Hum Genet 2006, 118:725-729.
130. van Zelm M.C., Reisli I., van der Burg M., Sira M.M., Suga K., Sekiguchi T., et al. An antibody-deficiency syndrome due to mutations in the CD19 gene. N Engl J Med 2006, 354:1901-1912.
131. Kanegane H., Agematsu K., Futatani T., Castano D., van Noesel CJ., van Tol MJ., et al. Novel mutations in a Japanese patient with CD19 deficiency. Genes Immun 2007, 8:663-670.
132. Kuijpers T.W., Bende R.J., Baars P.A., Grummels A., Derks I.A., Dolman K.M., et al. CD20 deficiency in humans results in impaired T cell-independent antibody responses. J Clin Invest 2010, 120:214-222.
133. Thiel J., Kimmig L., Salzer U., Grudzien M., Lebrecht D., Hagena T., et al. Genetic CD21 deficiency is associated with hypogammaglobulinemia. J Allergy Clin Immunol 2012, 129:801-810.e6.
134. Salzer E., Daschkey S., Choo S., Gombert M., Santos-Valente E., Ginzel S., et al. Combined immunodeficiency with life-threatening EBV-associated lymphoproliferative disorder in patients lacking functional CD27. Haematologica 2013, 98:473-478.
135. van Montfrans J.M., Hoepelman A.I., Otto S., van Gijn M., van de Corput L., de Weger RA., et al. CD27 deficiency is associated with combined immunodeficiency and persistent symptomatic EBV viremia. J Allergy Clin Immunol 2012, 129:787-793.e6.
136. van Zelm M.C., Smet J., Adams B., Mascart F., Schandene L., Janssen F., et al. CD81 gene defect in humans disrupts CD19 complex formation and leads to antibody deficiency. J Clin Invest 2010, 120:1265-1274.
137. Kuehn H.S., Ouyang W., Lo B., Deenick E.K., Niemela J.E., Avery D.T., et al. Immune dysregulation in human subjects with heterozygous germline mutations in CTLA4. Science 2014, 345:1623-1627.
138. Schubert D., Bode C., Kenefeck R., Hou T.Z., Wing J.B., Kennedy A., et al. Autosomal dominant immune dysregulation syndrome in humans with CTLA4 mutations. Nat Med 2014, 20:1410-1416.
139. Grimbacher B., Hutloff A., Schlesier M., Glocker E., Warnatz K., Drager R., et al. Homozygous loss of ICOS is associated with adult-onset common variable immunodeficiency. Nat Immunol 2003, 4:261-268.
140. Takahashi N., Matsumoto K., Saito H., Nanki T., Miyasaka N., Kobata T., et al. Impaired CD4 and CD8 effector function and decreased memory T cell populations in ICOS-deficient patients. J Immunol 2009, 182:5515-5527.
141. Kotlarz D., Zietara N., Milner J.D., Klein C. Human IL-21 and IL-21R deficiencies: two novel entities of primary immunodeficiency. Curr Opin Pediatr 2014, 26:704-712.
142. Kotlarz D., Zietara N., Uzel G., Weidemann T., Braun C.J., Diestelhorst J., et al. Loss-of-function mutations in the IL-21 receptor gene cause a primary immunodeficiency syndrome. J Exp Med 2013, 210:433-443.
143. Salzer E., Kansu A., Sic H., Majek P., Ikinciogullari A., Dogu F.E., et al. Early-onset inflammatory bowel disease and common variable immunodeficiency-like disease caused by IL-21 deficiency. J Allergy Clin Immunol 2014, 133:1651-1659.e12.
144. Alangari A., Alsultan A., Adly N., Massaad M.J., Kiani I.S., Aljebreen A., et al. LPS-responsive beige-like anchor (LRBA) gene mutation in a family with inflammatory bowel disease and combined immunodeficiency. J Allergy Clin Immunol 2012, 130:481-488.e2.
145. Burns S.O., Zenner H.L., Plagnol V., Curtis J., Mok K., Eisenhut M., et al. LRBA gene deletion in a patient presenting with autoimmunity without hypogammaglobulinemia. J Allergy Clin Immunol 2012, 130:1428-1432.
146. Lopez-Herrera G., Tampella G., Pan-Hammarstrom Q., Herholz P., Trujillo-Vargas C.M., Phadwal K., et al. Deleterious mutations in LRBA are associated with a syndrome of immune deficiency and autoimmunity. Am J Hum Genet 2012, 90:986-1001.
147. Chen K., Coonrod E.M., Kumanovics A., Franks Z.F., Durtschi J.D., Margraf R.L., et al. Germline mutations in NFKB2 implicate the noncanonical NF-kappaB pathway in the pathogenesis of common variable immunodeficiency. Am J Hum Genet 2013, 93:812-824.
148. Liu Y., Hanson S., Gurugama P., Jones A., Clark B., Ibrahim M.A. Novel NFKB2 mutation in early-onset CVID. J Clin Immunol 2014, 34:686-690.
149. Angulo I., Vadas O., Garcon F., Banham-Hall E., Plagnol V., Leahy T.R., et al. Phosphoinositide 3-kinase delta gene mutation predisposes to respiratory infection and airway damage. Science 2013, 342:866-871.
150. Crank M.C., Grossman J.K., Moir S., Pittaluga S., Buckner C.M., Kardava L., et al. Mutations in PIK3CD can cause hyper IgM syndrome (HIGM) associated with increased cancer susceptibility. J Clin Immunol 2014, 34:272-276.
151. Lucas C.L., Kuehn H.S., Zhao F., Niemela J.E., Deenick E.K., Palendira U., et al. Dominant-activating germline mutations in the gene encoding the PI(3)K catalytic subunit p110delta result in T cell senescence and human immunodeficiency. Nat Immunol 2014, 15:88-97.
152. Alkhairy O.K., Rezaei N., Graham R.R., Abolhassani H., Borte S., Hultenby K., et al. RAC2 loss-of-function mutation in 2 siblings with characteristics of common variable immunodeficiency. J Allergy Clin Immunol 2015, 135:1380-1384.e5.
153. Wang H.Y., Ma C.A., Zhao Y., Fan X., Zhou Q., Edmonds P., et al. Antibody deficiency associated with an inherited autosomal dominant mutation in TWEAK. Proc Natl Acad Sci U S A 2013, 110:5127-5132.
154. Al-Herz W., Bousfiha A., Casanova J.L., hatila T., Conley M.E., Cunningham-Rundles C., et al. Primary immunodeficiency diseases: an update on the classification from the International Union of Immunological Societies Expert Committee for Primary Immunodeficiency. Front Immunol 2014, 5:162.
155. Park J.H., Resnick E.S., Cunningham-Rundles C. Perspectives on common variable immune deficiency. Ann N Y Acad Sci 2011, 1246:41-49.
156. Liadaki K., Sun J., Hammarstrom L., Pan-Hammarstrom Q. New facets of antibody deficiencies. Curr Opin Immunol 2013, 25:629-638.
157. Castigli E., Wilson S.A., Garibyan L., Rachid R., Bonilla F., Schneider L., et al. TACI is mutant in common variable immunodeficiency and IgA deficiency. Nat Genet 2005, 37:829-834.
158. Salzer U., Chapel H.M., Webster A.D., Pan-Hammarstrom Q., Schmitt-Graeff A., Schlesier M., et al. Mutations in TNFRSF13B encoding TACI are associated with common variable immunodeficiency in humans. Nat Genet 2005, 37:820-828.
159. Pan-Hammarstrom Q., Salzer U., Du L., Bjorkander J., Cunningham-Rundles C., Nelson D.L., et al. Reexamining the role of TACI coding variants in common variable immunodeficiency and selective IgA deficiency. Nat Genet 2007, 39:429-430.
160. Salzer U., Bacchelli C., Buckridge S., Pan-Hammarstrom Q., Jennings S., Lougaris V., et al. Relevance of biallelic versus monoallelic TNFRSF13B mutations in distinguishing disease-causing from risk-increasing TNFRSF13B variants in antibody deficiency syndromes. Blood 2009, 113:1967-1976.
161. Warnatz K., Salzer U., Rizzi M., Fischer B., Gutenberger S., Bohm J., et al. B-cell activating factor receptor deficiency is associated with an adult-onset antibody deficiency syndrome in humans. Proc Natl Acad Sci U S A 2009, 106:13945-13950.
162. Pieper K., Rizzi M., Speletas M., Smulski C.R., Sic H., Kraus H., et al. A common single nucleotide polymorphism impairs B-cell activating factor receptor's multimerization, contributing to common variable immunodeficiency. J Allergy Clin Immunol 2014, 133:1222-1225.
163. Mullighan C.G., Marshall S.E., Bunce M., Welsh K.I. Variation in immunoregulatory genes determines the clinical phenotype of common variable immunodeficiency. Genes Immun 1999, 1:137-148.
164. Mullighan C.G., Marshall S.E., Welsh K.I. Mannose binding lectin polymorphisms are associated with early age of disease onset and autoimmunity in common variable immunodeficiency. Scand J Immunol 2000, 51:111-122.
165. Sansom M.E., Ferry B.L., Sherrell Z.P., Chapel H.M. A preliminary assessment of alpha-1 antitrypsin S and Z deficiency allele frequencies in common variable immunodeficiency patients with and without bronchiectasis. Clin Exp Immunol 2002, 130:489-494.
166. Alper C.A., Husain Z., Larsen C.E., Dubey D.P., Stein R., Day C., et al. Incomplete penetrance of susceptibility genes for MHC-determined immunoglobulin deficiencies in monozygotic twins discordant for type 1 diabetes. J Autoimmun 2006, 27:89-95.
167. Cunningham-Rundles C. Human B cell defects in perspective. Immunol Res 2012, 54:227-232.
168. Fedor M.E., Rubinstein A. Effects of long-term low-dose corticosteroid therapy on humoral immunity. Ann Allergy Asthma Immunol 2006, 97:113-116.
169. National Center for Immunization and Respiratory Diseases General recommendations on immunization-recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep 2011, 60:1-64.
170. Kerneis S., Launay O., Ancelle T., Iordache L., Naneix-Laroche V., Mechai F., et al. Safety and immunogenicity of yellow fever 17D vaccine in adults receiving systemic corticosteroid therapy: an observational cohort study. Arthritis Care Res (Hoboken) 2013, 65:1522-1528.
171. Hanania N.A., Sockrider M., Castro M., Holbrook J.T., Tonascia J., Wise R., et al. Immune response to influenza vaccination in children and adults with asthma: effect of corticosteroid therapy. J Allergy Clin Immunol 2004, 113:717-724.
172. Zielen S., Buhring I., Strnad N., Reichenbach J., Hofmann D. Immunogenicity and tolerance of a 7-valent pneumococcal conjugate vaccine in nonresponders to the 23-valent pneumococcal vaccine. Infect Immun 2000, 68:1435-1440.
173. Leinonen M., Sakkinen A., Kalliokoski R., Luotonen J., Timonen M., Makela P.H., et al. Antibody response to 14-valent pneumococcal capsular polysaccharide vaccine in pre-school age children. Pediatr Infect Dis 1986, 5:39-44.
174. Balloch A., Licciardi P.V., Russell F.M., Mulholland E.K., Tang M.L. Infants aged 12 months can mount adequate serotype-specific IgG responses to pneumococcal polysaccharide vaccine. J Allergy Clin Immunol 2010, 126:395-397.
175. Licciardi P.V., Balloch A., Russell F.M., Burton R.L., Lin J., Nahm M.H., et al. Pneumococcal polysaccharide vaccine at 12 months of age produces functional immune responses. J Allergy Clin Immunol 2012, 129:794-800.e2.
176. Siber G.R., Chang I., Baker S., Fernsten P., O'Brien K.L., Santosham M., et al. Estimating the protective concentration of anti-pneumococcal capsular polysaccharide antibodies. Vaccine 2007, 25:3816-3826.
177. Cavaliere F.M., Milito C., Martini H., Schlesier M., Drager R., Schutz K., et al. Quantification of IgM and IgA anti-pneumococcal capsular polysaccharides by a new ELISA assay: a valuable diagnostic and prognostic tool for common variable immunodeficiency. J Clin Immunol 2013, 33:838-846.
178. Paris K., Sorensen R.U. Assessment and clinical interpretation of polysaccharide antibody responses. Ann Allergy Asthma Immunol 2007, 99:462-464.
179. Orange J.S., Ballow M., Stiehm E.R., Ballas Z.K., Chinen J., De La Morena M., et al. Use and interpretation of diagnostic vaccination in primary immunodeficiency: a working group report of the Basic and Clinical Immunology Interest Section of the American Academy of Allergy, Asthma & Immunology. J Allergy Clin Immunol 2012, 130:S1-S24.
180. Ferry B.L., Misbah S.A., Stephens P., Sherrell Z., Lythgoe H., Bateman E., et al. Development of an anti-Salmonella typhi Vi ELISA: assessment of immunocompetence in healthy donors. Clin Exp Immunol 2004, 136:297-303.
181. Gelfand E.W., Ochs H.D., Shearer W.T. Controversies in IgG replacement therapy in patients with antibody deficiency diseases. J Allergy Clin Immunol 2013, 131:1001-1005.
182. Fried A.J., Altrich M.L., Liu H., Halsey J.F., Bonilla F.A. Correlation of pneumococcal antibody concentration and avidity with patient clinical and immunologic characteristics. J Clin Immunol 2013, 33:847-856.
183. Chovancova Z., Vlkova M., Litzman J., Lokaj J., Thon V. Antibody forming cells and plasmablasts in peripheral blood in CVID patients after vaccination. Vaccine 2011, 29:4142-4150.
184. Stiehm E.R., Keller M.A., Vyas G.N. Preparation and use of therapeutic antibodies primarily of human origin. Biologicals 2008, 36:363-374.
185. Bonagura V.R. Using intravenous immunoglobulin (IVIG) to treat patients with primary immune deficiency disease. J Clin Immunol 2013, 33:S90-S94.
186. Lucas M., Lee M., Lortan J., Lopez-Granados E., Misbah S., Chapel H. Infection outcomes in patients with common variable immunodeficiency disorders: relationship to immunoglobulin therapy over 22 years. J Allergy Clin Immunol 2010, 125:1354-1360.e4.
187. Berger M., Jolles S., Orange J.S., Sleasman J.W. Bioavailability of IgG administered by the subcutaneous route. J Clin Immunol 2013, 33:984-990.
188. Lucas M., Hugh-Jones K., Welby A., Misbah S., Spaeth P., Chapel H. Immunomodulatory therapy to achieve maximum efficacy: doses, monitoring, compliance, and self-infusion at home. J Clin Immunol 2010, 30:S84-S89.
189. Orange J.S., Belohradsky B.H., Berger M., Borte M., Hagan J., Jolles S., et al. Evaluation of correlation between dose and clinical outcomes in subcutaneous immunoglobulin replacement therapy. Clin Exp Immunol 2012, 169:172-181.
190. Orange J.S., Grossman W.J., Navickis R.J., Wilkes M.M. Impact of trough IgG on pneumonia incidence in primary immunodeficiency: a meta-analysis of clinical studies. Clin Immunol 2010, 137:21-30.
191. Haddad E., Berger M., Wang E.C., Jones C.A., Bexon M., Baggish J.S. Higher doses of subcutaneous IgG reduce resource utilization in patients with primary immunodeficiency. J Clin Immunol 2012, 32:281-289.
192. Jolles S., Borte M., Nelson R.P., Rojavin M., Bexon M., Lawo J.P., et al. Long-term efficacy, safety, and tolerability of Hizentra(R) for treatment of primary immunodeficiency disease. Clin Immunol 2014, 150:161-169.
193. Brennan V.M., Cochrane S., Fletcher C., Hendy D., Powell P. Surveillance of adverse reactions in patients self-infusing intravenous immunoglobulin at home. J Clin Immunol 1995, 15:116-119.
194. Brennan V.M., Salome-Bentley N.J., Chapel H.M. Immunology Nurses Study. Prospective audit of adverse reactions occurring in 459 primary antibody-deficient patients receiving intravenous immunoglobulin. Clin Exp Immunol 2003, 133:247-251.
195. Horn J., Thon V., Bartonkova D., Salzer U., Warnatz K., Schlesier M., et al. Anti-IgA antibodies in common variable immunodeficiency (CVID): diagnostic workup and therapeutic strategy. Clin Immunol 2007, 122:156-162.
196. Rachid R., Castells M., Cunningham-Rundles C., Bonilla F.A. Association of anti-IgA antibodies with adverse reactions to gamma-globulin infusion. J Allergy Clin Immunol 2011, 128:228-230.e1.
197. Borte M., Quinti I., Soresina A., Fernandez-Cruz E., Ritchie B., Schmidt D.S., et al. Efficacy and safety of subcutaneous vivaglobin(R) replacement therapy in previously untreated patients with primary immunodeficiency: a prospective, multicenter study. J Clin Immunol 2011, 31:952-961.
198. Gustafson R., Gardulf A., Hansen S., Leibl H., Engl W., Linden M., et al. Rapid subcutaneous immunoglobulin administration every second week results in high and stable serum immunoglobulin G levels in patients with primary antibody deficiencies. Clin Exp Immunol 2008, 152:274-279.
199. Bonilla F.A. Pharmacokinetics of immunoglobulin administered via intravenous or subcutaneous routes. Immunol Allergy Clin North Am 2008, 28:803-819. ix.
200. Waniewski J., Gardulf A., Hammarstrom L. Bioavailability of gamma-globulin after subcutaneous infusions in patients with common variable immunodeficiency. J Clin Immunol 1994, 14:90-97.
201. Sundin U., Nava S., Hammarstrom L. Induction of unresponsiveness against IgA in IgA-deficient patients on subcutaneous immunoglobulin infusion therapy. Clin Exp Immunol 1998, 112:341-346.
202. Gardulf A., Hammarstrom L., Smith C.I. Home treatment of hypogammaglobulinaemia with subcutaneous gammaglobulin by rapid infusion. Lancet 1991, 338:162-166.
203. Fasth A., Nystrom J. Safety and efficacy of subcutaneous human immunoglobulin in children with primary immunodeficiency. Acta Paediatr 2007, 96:1474-1478.
204. Gardulf A., Nicolay U. Replacement IgG therapy and self-therapy at home improve the health-related quality of life in patients with primary antibody deficiencies. Curr Opin Allergy Clin Immunol 2006, 6:434-442.
205. Wasserman R.L. Overview of recombinant human hyaluronidase-facilitated subcutaneous infusion of IgG in primary immunodeficiencies. Immunotherapy 2014, 6:553-567.
206. Chapel H., Brennan V., Delson E. Immunoglobulin replacement therapy by self-infusion at home. Clin Exp Immunol 1988, 73:160-162.
207. Martin A., Lavoie L., Goetghebeur M., Schellenberg R. Economic benefits of subcutaneous rapid push versus intravenous immunoglobulin infusion therapy in adult patients with primary immune deficiency. Transfus Med 2013, 23:55-60.
208. Fasth A., Nystrom J. Quality of life and health-care resource utilization among children with primary immunodeficiency receiving home treatment with subcutaneous human immunoglobulin. J Clin Immunol 2008, 28:370-378.
209. Dichtelmuller H.O., Biesert L., Fabbrizzi F., Falbo A., Flechsig E., Groner A., et al. Contribution to safety of immunoglobulin and albumin from virus partitioning and inactivation by cold ethanol fractionation: a data collection from Plasma Protein Therapeutics Association member companies. Transfusion 2011, 51:1412-1430.
210. Orbach H., Katz U., Sherer Y., Shoenfeld Y. Intravenous immunoglobulin: adverse effects and safe administration. Clin Rev Allergy Immunol 2005, 29:173-184.
211. Benadiba J., Robitaille N., Lambert G., Itaj N.K., Pastore Y. Intravenous immunoglobulin-associated thrombosis: is it such a rare event? Report of a pediatric case and of the Quebec Hemovigilance System. Transfusion 2015, 55:571-575.
212. Desborough M.J., Miller J., Thorpe S.J., Murphy M.F., Misbah S.A. Intravenous immunoglobulin-induced haemolysis: a case report and review of the literature. Transfus Med 2014, 24:219-226.
213. Chua I., Lagos M., Charalambous B.M., Workman S., Chee R., Grimbacher B. Pathogen-specific IgG antibody levels in immunodeficient patients receiving immunoglobulin replacement do not provide additional benefit to therapeutic management over total serum IgG. J Allergy Clin Immunol 2011, 127:1410-1411.
214. Junker A.K., Bonilla F.A., Sullivan K.E. How to flee the flu. Clin Immunol 2004, 112:219-220.
215. Buckley R.H., Ballas Z., Ballow M., Blaese M., Bonilla F.A., Conley M.E., et al. Recommendations for live viral and bacterial vaccines in immunodeficient patients and their close contacts. J Allergy Clin Immunol 2014, 133:961-966.
216. Nobre F.A., Gonzalez I.G., Simao R.M., de Moraes Pinto M.I., Costa-Carvalho BT. Antibody levels to tetanus, diphtheria, measles and varicella in patients with primary immunodeficiency undergoing intravenous immunoglobulin therapy: a prospective study. BMC Immunol 2014, 15:26.
217. Misbah S.A., Lawrence P.A., Kurtz J.B., Chapel H.M. Prolonged faecal excretion of poliovirus in a nurse with common variable hypogammaglobulinaemia. Postgrad Med J 1991, 67:301-303.
218. Bonilla F.A., Bernstein I.L., Khan D.A., Ballas Z.K., Chinen J., Frank M.M., et al. Practice parameter for the diagnosis and management of primary immunodeficiency. Ann Allergy Asthma Immunol 2005, 94:S1-S63.
219. Lopez-Boado Y.S., Rubin B.K. Macrolides as immunomodulatory medications for the therapy of chronic lung diseases. Curr Opin Pharmacol 2008, 8:286-291.
220. Ilowite J., Spiegler P., Chawla S. Bronchiectasis: new findings in the pathogenesis and treatment of this disease. Curr Opin Infect Dis 2008, 21:163-167.
221. Altenburg J., de Graaff C.S., Stienstra Y., Sloos J.H., van Haren EH., Koppers R.J., et al. Effect of azithromycin maintenance treatment on infectious exacerbations among patients with non-cystic fibrosis bronchiectasis: the BAT randomized controlled trial. JAMA 2013, 309:1251-1259.
222. Wong C., Jayaram L., Karalus N., Eaton T., Tong C., Hockey H., et al. Azithromycin for prevention of exacerbations in non-cystic fibrosis bronchiectasis (EMBRACE): a randomised, double-blind, placebo-controlled trial. Lancet 2012, 380:660-667.
223. Kellett F., Robert N.M. Nebulised 7% hypertonic saline improves lung function and quality of life in bronchiectasis. Respir Med 2011, 105:1831-1835.
224. Quartier P., Foray S., Casanova J.L., Hau-Rainsard I., Blanche S., Fischer A. Enteroviral meningoencephalitis in X-linked agammaglobulinemia: intensive immunoglobulin therapy and sequential viral detection in cerebrospinal fluid by polymerase chain reaction. Pediatr Infect Dis J 2000, 19:1106-1108.
225. Onbasi K., Gunsar F., Sin A.Z., Ardeniz O., Kokuludag A., Sebik F. Common variable immunodeficiency (CVID) presenting with malabsorption due to giardiasis. Turk J Gastroenterol 2005, 16:111-113.
226. Spickett G.P., Zhang J.G., Green T., Shrimankar J. Granulomatous disease in common variable immunodeficiency: effect on immunoglobulin replacement therapy and response to steroids and splenectomy. J Clin Pathol 1996, 49:431-434.
227. Longhurst H.J., O'Grady C., Evans G., De Lord C., Hughes A., Cavenagh J., et al. Anti-D immunoglobulin treatment for thrombocytopenia associated with primary antibody deficiency. J Clin Pathol 2002, 55:64-66.
228. Gobert D., Bussel J.B., Cunningham-Rundles C., Galicier L., Dechartres A., Berezne A., et al. Efficacy and safety of rituximab in common variable immunodeficiency-associated immune cytopenias: a retrospective multicentre study on 33 patients. Br J Haematol 2011, 155:498-508.
229. Seve P., Bourdillon L., Sarrot-Reynauld F., Ruivard M., Jaussaud R., Bouhour D., et al. Autoimmune hemolytic anemia and common variable immunodeficiency: a case-control study of 18 patients. Medicine (Baltimore) 2008, 87:177-184.
230. Wong G.K., Goldacker S., Winterhalter C., Grimbacher B., Chapel H., Lucas M., et al. Outcomes of splenectomy in patients with common variable immunodeficiency (CVID): a survey of 45 patients. Clin Exp Immunol 2013, 172:63-72.
231. Arnold D.F., Wiggins J., Cunningham-Rundles C., Misbah S.A., Chapel H.M. Granulomatous disease: distinguishing primary antibody disease from sarcoidosis. Clin Immunol 2008, 128:18-22.
232. Hatab A.Z., Ballas Z.K. Caseating granulomatous disease in common variable immunodeficiency treated with infliximab. J Allergy Clin Immunol 2005, 116:1161-1162.
233. Thatayatikom A., Thatayatikom S., White A.J. Infliximab treatment for severe granulomatous disease in common variable immunodeficiency: a case report and review of the literature. Ann Allergy Asthma Immunol 2005, 95:293-300.
234. Mannon P.J., Fuss I.J., Dill S., Friend J., Groden C., Hornung R., et al. Excess IL-12 but not IL-23 accompanies the inflammatory bowel disease associated with common variable immunodeficiency. Gastroenterology 2006, 131:748-756.
235. Baris S., Ercan H., Cagan H.H., Ozen A., Karakoc-Aydiner E., Ozdemir C., et al. Efficacy of intravenous immunoglobulin treatment in children with common variable immunodeficiency. J Investig Allergol Clin Immunol 2011, 21:514-521.
236. Chua I., Standish R., Lear S., Harbord M., Eren E., Raeiszadeh M., et al. Anti-tumour necrosis factor-alpha therapy for severe enteropathy in patients with common variable immunodeficiency (CVID). Clin Exp Immunol 2007, 150:306-311.
237. Chase N.M., Verbsky J.W., Hintermeyer M.K., Waukau J.K., Tomita-Mitchell A., Casper J.T., et al. Use of combination chemotherapy for treatment of granulomatous and lymphocytic interstitial lung disease (GLILD) in patients with common variable immunodeficiency (CVID). J Clin Immunol 2013, 33:30-39.
238. Davies C.W., Juniper M.C., Gray W., Gleeson F.V., Chapel H.M., Davies R.J. Lymphoid interstitial pneumonitis associated with common variable hypogammaglobulinaemia treated with cyclosporin A. Thorax 2000, 55:88-90.
239. Rizzi M., Neumann C., Fielding A.K., Marks R., Goldacker S., Thaventhiran J., et al. Outcome of allogeneic stem cell transplantation in adults with common variable immunodeficiency. J Allergy Clin Immunol 2011, 128:1371-1374.e2.
240. Wehr C., Gennery A.R., Lindemans C., Schulz A., Hoenig M., Marks R., et al. Multicenter experience in hematopoietic stem cell transplantation for serious complications of common variable immunodeficiency. J Allergy Clin Immunol 2015, 135:988-997.e6.
241. Eijkhout H.W., van Der Meer J.W., Kallenberg C.G., Weening R.S., van Dissel JT., Sanders L.A., et al. The effect of two different dosages of intravenous immunoglobulin on the incidence of recurrent infections in patients with primary hypogammaglobulinemia: a randomized, double-blind, multicenter crossover trial. Ann Intern Med 2001, 135:165-174.
242. Garcia-Lloret M., McGhee S., Chatila T.A. Immunoglobulin replacement therapy in children. Immunol Allergy Clin North Am 2008, 28:833-849. ix.
243. Piatosa B., Pac M., Siewiera K., Klaudel-Dreszler M., Heropolitanska-Pliszka E., et al. Common variable immune deficiency in children-clinical characteristics varies depending on defect in peripheral B cell maturation. J Clin Immunol 2013, 33:731-741.
244. Aydogan M., Eifan A.O., Gocmen I., Ozdemir C., Bahceciler N.N., Barlan I.B. Clinical and immunologic features of pediatric patients with common variable immunodeficiency and respiratory complications. J Investig Allergol Clin Immunol 2008, 18:260-265.
245. Touw C.M., van de Ven A.A., de Jong P.A., Terheggen-Lagro S., Beek E., Sanders E.A., et al. Detection of pulmonary complications in common variable immunodeficiency. Pediatr Allergy Immunol 2010, 21:793-805.
246. Llobet M.P., Soler-Palacin P., Detkova D., Hernandez M., Caragol I., Espanol T. Common variable immunodeficiency: 20-yr experience at a single centre. Pediatr Allergy Immunol 2009, 20:113-118.
247. Karakoc-Aydiner E., Ozen A.O., Baris S., Ercan H., Ozdemir C., Barlan I.B. Alterations in humoral immunity is common among family members of CVID patients. J Investig Allergol Clin Immunol 2014, 24:346-351.
248. Gardulf A., Andersson E., Lindqvist M., Hansen S., Gustafson R. Rapid subcutaneous IgG replacement therapy at home for pregnant immunodeficient women. J Clin Immunol 2001, 21:150-154.
249. Brinker K.A., Silk H.J. Common variable immune deficiency and treatment with intravenous immunoglobulin during pregnancy. Ann Allergy Asthma Immunol 2012, 108:464-465.
250. Cunningham-Rundles C. Key aspects for successful immunoglobulin therapy of primary immunodeficiencies. Clin Exp Immunol 2011, 164:16-19.
251. Hypogammaglobulinaemia in the United Kingdom: summary report of a Medical Research Council working-party. Lancet 1969, 1:163-168.
252. Hermaszewski R.A., Webster A.D. Primary hypogammaglobulinaemia: a survey of clinical manifestations and complications. Q J Med 1993, 86:31-42.
253. Dorsey M.J., Orange J.S. Impaired specific antibody response and increased B-cell population in transient hypogammaglobulinemia of infancy. Ann Allergy Asthma Immunol 2006, 97:590-595.
254. Morinishi Y., Imai K., Nakagawa N., Sato H., Horiuchi K., Ohtsuka Y., et al. Identification of severe combined immunodeficiency by T-cell receptor excision circles quantification using neonatal guthrie cards. J Pediatr 2009, 155:829-833.
255. Nakagawa N., Imai K., Kanegane H., Sato H., Yamada M., Kondoh K., et al. Quantification of kappa-deleting recombination excision circles in Guthrie cards for the identification of early B-cell maturation defects. J Allergy Clin Immunol 2011, 128:223-225.e2.
256. Aghamohammadi A., Moin M., Kouhi A., Mohagheghi M.A., Shirazi A., Rezaei N., et al. Chromosomal radiosensitivity in patients with common variable immunodeficiency. Immunobiology 2008, 213:447-454.
257. Serra G., Milito C., Mitrevski M., Granata G., Martini H., Pesce A.M., et al. Lung MRI as a possible alternative to CT scan for patients with primary immune deficiencies and increased radiosensitivity. Chest 2011, 140:1581-1589.
258. Gabriel S.E., Normand S.L. Getting the methods right-the foundation of patient-centered outcomes research. N Engl J Med 2012, 367:787-790.
259. Kaveri S.V., Maddur M.S., Hegde P., Lacroix-Desmazes S., Bayry J. Intravenous immunoglobulins in immunodeficiencies: more than mere replacement therapy. Clin Exp Immunol 2011, 164:2-5.